Covidien Looking to Acquire Companies With Annual Sales of $20-120M

Covidien CEO, Jose Almeida, said the company is looking to acquire companies with annual sales of $20-120 million in its vascular, respiratory and surgical businesses, according to a Bloomberg News report.

Advertisement

According to Bloomberg, Covidien announced or completed 20 deals in the past five years with an average size of $304 million.

Related Articles on Medical Devices:

Three-Quarters of California Biomedical Companies Delayed Research or Development Last Year
BG Medicine Names Eric Bouvier President and CEO
10 Recent FDA Medical Device Approvals

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.